Financings in Brief: Furon extends tender offer for Medex
This article was originally published in The Gray Sheet
Executive SummaryFuron extends tender offer for Medex: Furon's $23.50 per share tender offer for Medex stock, announced in November ("The Gray Sheet" Nov. 18, p. 8), is extended until 5 p.m. EST on Jan. 2, 1997. The offer had been set to expire on Dec. 19. Shortly before the earlier deadline, Furon reported that 5.1 mil. Medex shares had been tendered under the offer. Those shares, combined with shares agreed to be tendered by Medex management, represent about 82.3% of Medex' total outstanding common stock -- enough, Furon says, to enact the merger on a "short form" basis...
You may also be interested in...
According to the plaintiff, Unilever’s Pond’s Rejuveness Anti-Wrinkle Cream is defective insofar as tested product has been found to contain unlabeled mercury, constituting negligence that has resulted in user injuries. The plaintiff seeks certification of a transnational class and compensatory and punitive damages, among other relief.
HBW Product Launches: New Chapter Collagen, Alkamind Acid-Kicking, GNC China, Tetra Bio Canada, More
GNC, Harbin launch supplements in China following regulatory approval; Bee Gone expands with allergy swabs; Bed, Bath & Beyond expands distribution of CBDMedic personal care products promoted by Rob Gronkowski; Tetra Bio has Canadian OK For hemorrhoid and pain relief OTCs, US and European pending; Agrozen offers Urban Daze CBD products; New Chapter portfolio expansion also includes fermented vitamins, elderberry supplements and magnesium; and Alkamind’s Acid-Kicking Coffee Alkalizer creamers help neutralize acid from coffee.
In joint complaint, the FTC and New York Attorney General allege scheme to block generic Daraprim and maintain exorbitant list price; they cite hundreds of emails the incarcerated Shkreli has exchanged with co-defendant in last six months.